BACKGROUND: In recent years, the non-medical use of prescription drugs (NMUPD) has increased dramatically and has been associated with adverse health outcomes. Prior work has not examined this behavior in large samples of transgender adults. METHODS: Transgender adults (N=155) recruited from community venues in the Mid-Atlantic region completed anonymous, self-administered surveys assessing demographic information, NMUPD and other substance use, the non-medical use of hormones, psychosocial factors, and psychiatric symptoms. RESULTS: Overall, 26.5% of participants reported lifetime NMUPD with the most commonly reported medications used non-medically being prescription analgesics (23.9%), anxiolytics (17.4%), stimulants (13.5%), and sedatives (8.4%). Non-medical use of hormones was also frequently reported (30.3%). Participants reporting NMUPD were also more likely to report the use of illicit drugs. NMUPD, but not the non-medical use of hormones, was associated with lower self-esteem, more gender identity-based discrimination, and more self-reported symptoms of anxiety, depression, and somatic distress. Psychiatric symptoms remained statistically associated with NMUPD after controlling for demographic factors and other substance use. CONCLUSIONS: Prescription drug misuse was relatively common in this sample and was robustly associated with emotional distress. Substance use and mental health interventions for this population may benefit from incorporating the assessment and treatment of NMUPD.
BACKGROUND: In recent years, the non-medical use of prescription drugs (NMUPD) has increased dramatically and has been associated with adverse health outcomes. Prior work has not examined this behavior in large samples of transgender adults. METHODS: Transgender adults (N=155) recruited from community venues in the Mid-Atlantic region completed anonymous, self-administered surveys assessing demographic information, NMUPD and other substance use, the non-medical use of hormones, psychosocial factors, and psychiatric symptoms. RESULTS: Overall, 26.5% of participants reported lifetime NMUPD with the most commonly reported medications used non-medically being prescription analgesics (23.9%), anxiolytics (17.4%), stimulants (13.5%), and sedatives (8.4%). Non-medical use of hormones was also frequently reported (30.3%). Participants reporting NMUPD were also more likely to report the use of illicit drugs. NMUPD, but not the non-medical use of hormones, was associated with lower self-esteem, more gender identity-based discrimination, and more self-reported symptoms of anxiety, depression, and somatic distress. Psychiatric symptoms remained statistically associated with NMUPD after controlling for demographic factors and other substance use. CONCLUSIONS: Prescription drug misuse was relatively common in this sample and was robustly associated with emotional distress. Substance use and mental health interventions for this population may benefit from incorporating the assessment and treatment of NMUPD.
Keywords:
Non-medical drug use of prescription drugs (NMUPD); Prescription drugs; Psychiatric symptoms associated with non-medical drug use; Substance use; Transgender
Authors: John R Blosnich; Mary C Marsiglio; Shasha Gao; Adam J Gordon; Jillian C Shipherd; Michael Kauth; George R Brown; Michael J Fine Journal: Am J Public Health Date: 2016-01-21 Impact factor: 9.308
Authors: Elizabeth W Diemer; Julia D Grant; Melissa A Munn-Chernoff; David A Patterson; Alexis E Duncan Journal: J Adolesc Health Date: 2015-04-28 Impact factor: 5.012
Authors: Matthew J Mimiaga; Jaclyn M W Hughto; Katie B Biello; Christopher M Santostefano; Lisa M Kuhns; Sari L Reisner; Robert Garofalo Journal: J Acquir Immune Defic Syndr Date: 2019-06-01 Impact factor: 3.731
Authors: Sari L Reisner; Tonia Poteat; JoAnne Keatley; Mauro Cabral; Tampose Mothopeng; Emilia Dunham; Claire E Holland; Ryan Max; Stefan D Baral Journal: Lancet Date: 2016-06-17 Impact factor: 79.321